![](https://etimg.etb2bimg.com/thumb/msid-111968351,imgsize-84288,width-1200,height=765,overlay-ethealth/pharma/pharma-industry/pharma-industry-divided-on-budget-2024-focus-more-on-rd-api-cancer-drug-affordability.jpg)
Pharma industry divided on Budget 2024: Focus more on R&D, API, cancer drug affordability
Mumbai: The Union Budget 2024-25 has mostly been welcomed by the healthcare sector but has also sparked a spectrum of responses from industry leaders. The budget has been a mixed bag which reflects the optimism and also calls for greater support. The …